Iranian Red Crescent Medical Journal

Published by: Kowsar

Association Between Outcomes and Demographic Factors in an Azeri Turkish Population With Cystic Fibrosis: A Cross-Sectional Study in Iran From 2001 Through 2014

Leila Vahedi 1 , Morteza Jabarpoor-Bonyadi 2 , Morteza Ghojazadeh 1 , Hakimeh Hazrati 1 and Mandana Rafeey 3 , *
Authors Information
1 Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
2 Faculty of Natural Sciences, Center of Excellence for Biodiversity, University of Tabriz, Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
3 Tabriz Children’s Hospital, Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: April 01, 2016, 18 (4); e29615
  • Published Online: January 6, 2016
  • Article Type: Research Article
  • Received: April 29, 2015
  • Revised: June 8, 2015
  • Accepted: July 2, 2015
  • DOI: 10.5812/ircmj.29615

To Cite: Vahedi L, Jabarpoor-Bonyadi M, Ghojazadeh M, Hazrati H, Rafeey M. Association Between Outcomes and Demographic Factors in an Azeri Turkish Population With Cystic Fibrosis: A Cross-Sectional Study in Iran From 2001 Through 2014, Iran Red Crescent Med J. 2016 ; 18(4):e29615. doi: 10.5812/ircmj.29615.

Copyright © 2016, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Callaghan BD, Hoo AF, Dinwiddie R, Balfour-Lynn IM, Carr SB. Growth and lung function in Asian patients with cystic fibrosis. Arch Dis Child. 2005; 90(10): 1029-32[DOI][PubMed]
  • 2. Lannefors L, Lindgren A. Demographic transition of the Swedish cystic fibrosis community--results of modern care. Respir Med. 2002; 96(9): 681-5[PubMed]
  • 3. Fajac I, Bulteel V, Castellani C, Lee T, Derichs N, Drevinek P, et al. The european cystic fibrosis society–clinical trials network: An international network to optimize clinical research for a rare disease. Clin Investigation. 2013; 3(10): 921-6[DOI]
  • 4. Barr HL, Britton J, Smyth AR, Fogarty AW. Association between socioeconomic status, sex, and age at death from cystic fibrosis in England and Wales (1959 to 2008): cross sectional study. BMJ. 2011; 343[DOI][PubMed]
  • 5. Schippa S, Iebba V, Santangelo F, Gagliardi A, De Biase RV, Stamato A, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients. PLoS One. 2013; 8(4)[DOI][PubMed]
  • 6. Sweezey NB, Ratjen F. The cystic fibrosis gender gap: potential roles of estrogen. Pediatr Pulmonol. 2014; 49(4): 309-17[DOI][PubMed]
  • 7. Alibakhshi R, Zamani M. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients. Iran J Allergy Asthma Immunol. 2006; 5(1): 3-8[PubMed]
  • 8. Castellani C, Cuppens H, Macek MJr, Cassiman JJ, Kerem E, Durie P, et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros. 2008; 7(3): 179-96[DOI][PubMed]
  • 9. Taylor-Cousar JL, Zariwala MA, Burch LH, Pace RG, Drumm ML, Calloway H, et al. Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity. PLoS One. 2009; 4(1)[DOI][PubMed]
  • 10. Goeminne PC, Bijnens E, Nemery B, Nawrot TS, Dupont LJ. Impact of traffic related air pollution indicators on non-cystic fibrosis bronchiectasis mortality: a cohort analysis. Respir Res. 2014; 15: 108[DOI][PubMed]
  • 11. Ernst MM, Johnson MC, Stark LJ. Developmental and psychosocial issues in cystic fibrosis. Child Adolesc Psychiatr Clin N Am. 2010; 19(2): 263-83[DOI]
  • 12. Japoni A, Farshad S, Alborzi A. Pseudomonas aeruginosa: Burn infection, treatment and antibacterial resistance. Iran Red Crescent Med J. 2009; 2009(3): 244-53
  • 13. Abbott J, Morton AM, Musson H, Conway SP, Etherington C, Gee L, et al. Nutritional status, perceived body image and eating behaviours in adults with cystic fibrosis. Clin Nutr. 2007; 26(1): 91-9[DOI][PubMed]
  • 14. Damghanian M, Shariati M, Mirzaiinajmabadi K, Yunesian M, Emamian MH. Socioeconomic inequality and its determinants regarding infant mortality in iran. Iran Red Crescent Med J. 2014; 16(6)[DOI]
  • 15. Dodge JA, Lewis PA, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J. 2007; 29(3): 522-6[DOI][PubMed]
  • 16. Mahadeva R, Webb K, Westerbeek RC, Carroll NR, Dodd ME, Bilton D, et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ. 1998; 316(7147): 1771-5[PubMed]
  • 17. Zemanick ET, Harris JK, Conway S, Konstan MW, Marshall B, Quittner AL, et al. Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy. J Cyst Fibros. 2010; 9(1): 1-16[DOI][PubMed]
  • 18. Dankert-Roelse JE, Merelle ME. Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe. J Pediatr. 2005; 147(3 Suppl)-20[DOI][PubMed]
  • 19. Schechter MS, Shelton BJ, Margolis PA, Fitzsimmons SC. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med. 2001; 163(6): 1331-7[DOI][PubMed]
  • 20. Bonyadi M, Omrani O, Rafeey M, Bilan N. Spectrum of CFTR gene mutations in Iranian Azeri Turkish patients with cystic fibrosis. Genet Test Mol Biomarkers. 2011; 15(1-2): 89-92[DOI][PubMed]
  • 21. De Boeck K, Bulteel V, Tiddens H, Wagner T, Fajac I, Conway S, et al. Guideline on the design and conduct of cystic fibrosis clinical trials: The european cystic fibrosis society–clinical trials network (ECFS-CTN). J Cyst Fibros. 2011; 10-74[DOI]
  • 22. Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ, et al. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med. 2001; 3(2): 149-54[PubMed]
  • 23. Hamamy H. Consanguineous marriages : Preconception consultation in primary health care settings. J Community Genet. 2012; 3(3): 185-92[DOI][PubMed]
  • 24. McCormick J, Mehta G, Olesen HV, Viviani L, Macek MJr, Mehta A, et al. Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis. Lancet. 2010; 375(9719): 1007-13[DOI][PubMed]
  • 25. Szczesniak RD, Zou YU, Wetzel JD, Krause N, Grossoehme DH. Increased congregational support for parents of children with cystic fibrosis. J Relig Health. 2015; 54(2): 664-75
  • 26. Groeneveld IF, Sosa ES, Perez M, Fiuza-Luces C, Gonzalez-Saiz L, Gallardo C, et al. Health-related quality of life of Spanish children with cystic fibrosis. Qual Life Res. 2012; 21(10): 1837-45[DOI][PubMed]
  • 27. Arias Llorente RP, Bousono Garcia C, Diaz Martin JJ. Treatment compliance in children and adults with cystic fibrosis. J Cyst Fibros. 2008; 7(5): 359-67[DOI][PubMed]
  • 28. Zemanick ET, Wagner BD, Harris JK, Wagener JS, Accurso FJ, Sagel SD. Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures. Pediatr Pulmonol. 2010; 45(6): 569-77[DOI][PubMed]
  • 29. Szyndler JE, Towns SJ, van Asperen PP, McKay KO. Psychological and family functioning and quality of life in adolescents with cystic fibrosis. J Cyst Fibros. 2005; 4(2): 135-44[DOI][PubMed]
  • 30. Everhart RS, Fiese BH, Smyth JM, Borschuk A, Anbar RD. Family Functioning and Treatment Adherence in Children and Adolescents with Cystic Fibrosis. Pediatr Allergy Immunol Pulmonol. 2014; 27(2): 82-6[DOI][PubMed]
  • 31. McCormick J, Sims EJ, Green MW, Mehta G, Culross F, Mehta A. Comparative analysis of Cystic Fibrosis Registry data from the UK with USA, France and Australasia. J Cyst Fibros. 2005; 4(2): 115-22[DOI][PubMed]
  • 32. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008; 153(2)[DOI][PubMed]
  • 33. Lai HJ, Cheng Y, Cho H, Kosorok MR, Farrell PM. Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis. Am J Epidemiol. 2004; 159(6): 537-46[PubMed]
  • 34. Effect of family history on disclosure patterns of cystic fibrosis carrier status. American Journal of Medical Genetics Part C: Seminars in Medical Genetics
  • 35. El Mouzan MI, Al Salloum AA, Al Herbish AS, Qurachi MM, Al Omar AA. Consanguinity and major genetic disorders in Saudi children: a community-based cross-sectional study. Ann Saudi Med. 2008; 28(3): 169-73[PubMed]
  • 36. Bittles AH. Consanguineous marriage and childhood health. Dev Med Child Neurol. 2003; 45(8): 571-6[PubMed]
  • 37. Verma N, Bush A, Buchdahl R. Is there still a gender gap in cystic fibrosis? CHEST J. 2005; 128(4): 2824-34
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments